Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Intravenous Rexin-G in Osteosarcoma
This study has been completed.
Study NCT00572130   Information provided by Epeius Biotechnologies

First Received on December 10, 2007.   Last Updated on June 9, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteosarcoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Sarcoma
Interventions listed in this trial
Rexin-G Dose 1
Rexin-G Dose 2
Sponsors listed in this trial
Epeius Biotechnologies


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services